Clonidine and Arterial disorder - a phase IV clinical study of FDA data

Summary:

Arterial disorder is reported as a side effect among people who take Clonidine (clonidine), especially for people who are male, 30-39 old, also take Prednisone, and have Transplant rejection.

The phase IV clinical study analyzes which people have Arterial disorder when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,645 Clonidine users. Check the latest studies of Clonidine.

What is Arterial disorder?

Arterial disorder is found to be associated with 327 drugs and 475 conditions by eHealthMe. Check the latest studies of Arterial disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 29 people (0.05%) have Arterial disorder.

Could Clonidine cause Arterial disorder?

Among these 29 people:

What is the gender of people who have Arterial disorder when taking Clonidine? *

female: 34.78 %
male: 65.22 %

What is the age of people who have Arterial disorder when taking Clonidine? *

What are other drugs people take besides Clonidine? *

Prednisone: 15 people, 51.72%
Amlodipine Besylate: 14 people, 48.28%
Magnesium: 13 people, 44.83%
Actemra: 13 people, 44.83%
Benadryl: 13 people, 44.83%
Calcium: 13 people, 44.83%
Tacrolimus: 12 people, 41.38%
Mycophenolate Mofetil: 12 people, 41.38%
Tylenol: 12 people, 41.38%
Sulfatrim: 8 people, 27.59%

What are other side effects people have besides Arterial disorder? *

Weight Increased: 16 people, 55.17%
Haematocrit Decreased: 14 people, 48.28%
Red Blood Cell Count Decreased: 14 people, 48.28%
Renal Tubular Necrosis (death of kidney tubules): 13 people, 44.83%
Lymphocyte Count Decreased: 13 people, 44.83%
Monocyte Count Increased: 13 people, 44.83%
Urine Protein/creatinine Ratio Increased: 13 people, 44.83%
Urine Albumin/creatinine Ratio Increased: 13 people, 44.83%
Blood Urea Increased: 13 people, 44.83%
Blood Alkaline Phosphatase Decreased: 13 people, 44.83%

What are the existing conditions these people have? *

Transplant Rejection (a transplant material is not worked): 13 people, 44.83%
Hiv Infection: 1 person, 3.45%
Bipolar Disorder (mood disorder): 1 person, 3.45%
Birth Control: 1 person, 3.45%
Cardiac Failure Congestive: 1 person, 3.45%
Chronic Renal Failure (kidney failure): 1 person, 3.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.45%
High Blood Cholesterol: 1 person, 3.45%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 3.45%
Sleep Disorder: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Arterial disorder?

- Check whether Arterial disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Clonidine (65,645 reports)

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arterial disorder:

Arterial disorder (327 drugs)

Browse all the conditions that are associated with Arterial disorder:

Arterial disorder (475 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.